Ivan Kovacik

This inventor holds 6 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignee: Biosensors International Group, Ltd.. Active years: 2016-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ivan Kovacik. Retrieved from https://idiyas.com/inventor/ivan-kovacik

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 6 (Patent Applications = 1)

% Patents Active = 100.0

CIPO Patents = 2

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 4.5

ph-index = 2

Forward Citations = 11(Granted Patents)

Company Filing History:

6 out of 59

Biosensors International Group, Ltd.

patents

Years Active: 2016-2023

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11780850 - Purification of rapamycin derivatives using temperature induced phase separation (2023-10-10),

2. 11046711 - Purification of rapamycin derivatives using temperature induced phase separation (2021-06-29),

3. 10597406 - Purification of rapamycin derivatives using temperature induced phase separation (2020-03-24),

4. 10202402 - Purification of rapamycin derivatives using temperature induced phase separation (2019-02-12),

5. 9598439 - Purification of rapamycin derivatives using temperature induced phase separation (2017-03-21),

6. 9434744 - Low temperature synthesis of rapamycin derivatives (2016-09-06),

Title: The Innovative Contributions of Ivan Kovacik

Introduction

Ivan Kovacik is a notable inventor based in Devens, Massachusetts. He has made significant contributions to the field of pharmaceuticals, particularly in the purification of rapamycin derivatives. With a total of six patents to his name, Kovacik's work has advanced the understanding and application of these important compounds.

Latest Patents

Kovacik's latest patents focus on the purification of rapamycin derivatives using temperature-induced phase separation. This innovative method provides techniques for obtaining purified rapamycin derivatives, including the purified form of Biolimus A9. Additionally, a crystalline form of Biolimus A9 is described in his patents, showcasing his commitment to enhancing the quality and efficacy of pharmaceutical products.

Career Highlights

Ivan Kovacik is currently employed at Biosensors International Group, Ltd., where he continues to push the boundaries of pharmaceutical innovation. His work has not only contributed to the company's success but has also had a broader impact on the industry.

Collaborations

Kovacik collaborates with talented professionals in his field, including Margaret W Kayo and Richard S Fornicola. These partnerships enhance the research and development efforts at Biosensors International Group, Ltd.

Conclusion

Ivan Kovacik's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a leading inventor. His work continues to influence the industry and improve the quality of pharmaceutical products.

Profile summary based on public USPTO records.